Systematic isolation of genes differentially expressed in normal and cancerous tissue of the pancreas

Pancreatology

Volumn 3, Issue 2, 2003, Pages 169-178

  Grützmann, Robert ^a   Pilarsky, Christian ^a   Staub, Eike ^b   Schmitt, Armin O ^b   Foerder, Melanie ^a   Specht, Thomas ^b   Hinzmann, Bernd ^b   Dahl, Edgar ^b   Alldinger, Ingo ^a   Rosenthal, Andre ^b   Ockert, Detlef ^a   Saeger, Hans Detlev ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b metaGen Pharmaceuticals GmbH   (Germany)

Author keywords

Expression profiling; Gene; Pancreatic cancer

Indexed keywords

ARTICLE; CANCER TISSUE; CARCINOGENESIS; COMPUTER PROGRAM; CONTROLLED STUDY; EXPRESSED SEQUENCE TAG; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE ISOLATION; HUMAN; HUMAN TISSUE; PANCREAS CARCINOMA; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; UPREGULATION;

EID: 0038395671     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000070087     Document Type: Article

References (35)

1. Parker SL, Tong T, Bolden S, Wingo PA: Cancer statistics, 1997. CA Cancer J Clin 1997;47:5-27.
2. Murr MM, Sarr MG, Oishi AJ, van Heerden JA: Pancreatic cancer. CA Cancer J Clin 1994;44:304-318.
3. Hilgers W, Kern SE: Molecular genetic basis of pancreatic adenocarcinoma. Genes Chromosomes Cancer 1999;26:1-12.
4. Bardi G, Johansson B, Pandis N, Mandahl N, Bak-Jensen E, Andren-Sandberg A, Mitelman F, Heim S: Karyotypic abnormalities in tumours of the pancreas. Br J Cancer 1993;67:1106-1112.
5. Griffin CA, Hruban RH, Morsberger LA, Ellingham T, Long PP, Jaffee EM, Hauda KM, Bohlander SK, Yeo CJ: Consistent chromosome abnormalities in adenocarcinoma of the pancreas. Cancer Res 1995;55:2394-2399.
6. Hahn SA, Seymour AB, Hoque AT, Schutte M, da Costa LT, Redston MS, Caldas C, Weinstein CL, Fischer A, Yeo CJ, et al: Allelotype of pancreatic adenocarcinoma using xenograft enrichment. Cancer Res 1995;55:4670-4675.
7. Solinas-Toldo S, Wallrapp C, Müller-Pillasch F, Bentz M, Gress T, Lichter P: Mapping of chromosomal imbalances in pancreatic carcinoma by comparative genomic hybridization. Cancer Res 1996;56:3803-3807.
8. Brat DJ, Hahn SA, Griffin CA, Yeo CJ, Kern SE, Hruban RH: The structural basis of molecular genetic deletions. An integration of classical cytogenetic and molecular analyses in pancreatic adenocarcinoma. Am J Pathol 1997;150:383-391.
9. Liang P, Pardee AB: Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 1992;257:967-971.
10. Gress TM, Wallrapp C, Frohme M, Müller-Pillasch F, Lacher U, Friess H, Büchler M, Adler G, Hoheisel JD: Identification of genes with specific expression in pancreatic cancer by cDNA representational difference analysis. Genes Chromosomes Cancer 1997;19:97-103.
11. Argani P, Iacobuzio-Donahue C, Ryu B, Rosty C, Goggins M, Wilentz RE, Murugesan SR, Leach SD, Jaffee E, Yeo CJ, Cameron JL, Kern SE, Hruban RH: Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: Identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE). Clin Cancer Res 2001;7:3862-3868.
12. Ryu B, Jones J, Blades NJ, Parmigiani G, Hollingsworth MA, Hruban RH, Kern SE: Relationships and differentially expressed genes among pancreatic cancers examined by large-scale serial analysis of gene expression. Cancer Res 2002;62:819-826.
13. Zuber J, Tchernitsa OI, Hinzmann B, Schmitz AC, Grips M, Hellriegel M, Sers C, Rosenthal A, Schafer R: A genome-wide survey of RAS transformation targets. Nat Genet 2000;24:144-152.
14. Friess H, Ding J, Kleeff J, Liao Q, Berberat PO, Hammer J, Büchler MW: Identification of disease-specific genes in chronic pancreatitis using DNA array technology. Ann Surg 2001;234:769-779.
15. Scheurle D, DeYoung MP, Binninger DM, Page H, Jahanzeb M, Narayanan R: Cancer gene discovery using digital differential display. Cancer Res 2000;60:4037-4043.
16. Adams MD, Kelley JM, Gocayne JD, Dubnick M, Polymeropoulos MH, Xiao H, Merril CR, Wu A, Olde B, Moreno RF, et al: Complementary DNA sequencing: Expressed sequence tags and human genome project. Science 1991;252:1651-1656.
17. Schmitt AO, Specht T, Beckmann G, Dahl E, Pilarsky CP, Hinzmann B, Rosenthal A: Exhaustive mining of EST libraries for genes differentially expressed in normal and tumour tissues. Nucleic Acids Res 1999;27:4251-4260.
18. Fannon MR: Gene expression in normal and disease states - identification of therapeutic targets. Trends Biotechnol 1996;14:294-298.
19. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ: Basic local alignment search tool. J Mol Biol 1990;215:403-410.
20. Kern SE: Molecular genetic alterations in ductal pancreatic adenocarcinomas. Med Clin North Am 2000;84:691-695, xi.
21. Ozaki K, Nagata M, Suzuki M, Fujiwara T, Miyoshi Y, Ishikawa O, Ohigashi H, Imaoka S, Takahashi E, Nakamura Y: Isolation and characterization of a novel human pancreas-specific gene, pancpin, that is down-regulated in pancreatic cancer cells. Genes Chromosomes Cancer 1998;22:179-185.
22. Gress TM, Müller-Pillasch F, Geng M, Zimmerhackl F, Zehetner G, Friess H, Büchler M, Adler G, Lehrach H: A pancreatic cancer-specific expression profile. Oncogene 1996;13:1819-1830.
23. Iacobuzio-Donahue CA, Maitra A, Shen-Ong GL, van Heek T, Ashfaq R, Meyer R, Walter K, Berg K, Hollingsworth MA, Cameron JL, Yeo CJ, Kern SE, Goggins M, Hruban RH: Discovery of novel tumor markers of pancreatic cancer using global gene expression technology. Am J Pathol 2002;160:1239-1249.
24. Sanvito F, Vivoli F, Gambini S, Santambrogio G, Catena M, Viale E, Veglia F, Donadini A, Biffo S, Marchisio PC: Expression of a highly conserved protein, p27BBP, during the progression of human colorectal cancer. Cancer Res 2000;60:510-516.
25. Biffo S, Sanvito F, Costa S, Preve L, Pignatelli R, Spinardi L, Marchisio PC: Isolation of a novel beta4 integrin-binding protein (p27(BBP)) highly expressed in epithelial cells. J Biol Chem 1997;272:30314-30321.
26. Noel A, Boulay A, Kebers F, Kannan R, Hajitou A, Calberg-Bacq CM, Basset P, Rio MC, Foidart JM: Demonstration in vivo that stromelysin-3 functions through its proteolytic activity. Oncogene 2000;19:1605-1612.
27. Rio MC, Lefebvre O, Santavicca M, Noel A, Chenard MP, Anglard P, Byrne JA, Okada A, Regnier CH, Masson R, Bellocq JP, Basset P: Stromelysin-3 in the biology of the normal and neoplastic mammary gland. J Mammary Gland Biol Neoplasia 1996;1:231-240.
28. von Marschall Z, Riecken EO, Rosewicz S: Stromelysin 3 is overexpressed in human pancreatic carcinoma and regulated by retinoic acid in pancreatic carcinoma cell lines. Gut 1998;43:692-698.
29. Clemmons DR, Jones JI, Busby WH, Wright G: Role of insulin-like growth factor binding proteins in modifying IGF actions. Ann NY Acad Sci 1993;692:10-21.
30. Glantschnig H, Varga F, Luegmayr E, Klaushofer K: Characterization of the mouse insulin-like growth factor binding protein 4 gene regulatory region and expression studies. DNA Cell Biol 1998;17:51-60.
31. Remacle-Bonnet MM, Garrouste FL, Pommier GJ: Surface-bound plasmin induces selective proteolysis of insulin-like-growth-factor (IGF)-binding protein-4 (IGFBP-4) and promotes autocrine IGF-II bio-availability in human colon-carcinoma cells. Int J Cancer 1997;72:835-843.
32. Barton CM, Staddon SL, Hughes CM, Hall PA, O'Sullivan C, Kloppel G, Theis B, Russell RC, Neoptolemos J, Williamson RC, et al: Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer. Br J Cancer 1991;64:1076-1082.
33. Casey G, Yamanaka Y, Friess H, Kobrin MS, Lopez ME, Büchler M, Beger HG, Korc M: p53 mutations are common in pancreatic cancer and are absent in chronic pancreatitis. Cancer Lett 1993;69:151-160.
34. Lukkonen A, Sorsa T, Salo T, Tervahartiala T, Koivunen E, Golub L, Simon S, Stenman UH: Down-regulation of trypsinogen-2 expression by chemically modified tetracyclines: Association with reduced cancer cell migration. Int J Cancer 2000;86:577-581.
35. Vingron M, Hoheisel J: Computational aspects of expression data. J Mol Med 1999;77:3-7.